(Q45129222)

9 December 2017

title

Liposomes modified with cyclic RGD peptide for tumor targeting (English)

1 reference

9 December 2017

3

1 reference

9 December 2017

Praveen K Dubey

1

1 reference

9 December 2017

Vivek Mishra

series ordinal

2

1 reference

9 December 2017

Sunil Mahor

series ordinal

4

1 reference

9 December 2017

S P Vyas

series ordinal

5

1 reference

9 December 2017

publication date

1 June 2004

1 reference

Journal of Drug Targeting

9 December 2017

published in

1 reference

9 December 2017

volume

12

1 reference

9 December 2017

issue

5

1 reference

9 December 2017

page(s)

257-264

1 reference

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Ligand-targeted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

A reevaluation of integrins as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Solid-phase synthesis of c(RGDfK) derivatives: on-resin cyclisation and lysine functionalisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860410001728040

10.1080/10611860410001728040

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference